secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-09-10T12:01:18+00:00
Accession:  0001193125-26-387267
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cerenome secures $21.3M senior secured convertible note facility with 3i Fund
-----------------------------------------------------------------------------

- Initial closing expected Sept 10, 2026; gross proceeds $3M; total notes $21,276,596 with 6% OID and 8% interest.
- Notes convertible at $2.74/share, floor $0.50; maturity one year; secured by first-priority lien on assets and CNSide equity.
- Royalty agreement: CNSide pays 2.5% of gross revenues quarterly, capped at 2.5% of outstanding note balance.
- Proceeds for working capital; company forecasts cash runway into 2028; additional tranches up to $15.96M available upon milestones.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526387267/0001193125-26-387267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526387267/d382364d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-387267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer